 |
2.0 |
Coronary Angioplasty and Stenting: Indications and Results
Mark E. Williams, MD.
|
Emerging New Agents in Diabetic Kidney Disease
Julia A. Lewis, MD.
|
Optimizing the Total Care of the Diabetic Patient with Kidney Disease - Lipids
Mark E. Molitch, MD.
|
1.5 |
Ethylene Glycol Poisoning
Man S. Oh, MD.
|
Permissive Hypercapnia in Acute Pulmonary Disorders -
Morbidity and Mortality and Treating the Respiratory Acidosis
Paul N. Lanken, MD.
|
2.0 |
Preservation of residual renal function in hemodialysis patients
Norbert Lameire, MD, PhD.
|
Literature Review: Non-Potassium Fluid-Electrolyte and Acid-Base Disorders
Biff F. Palmer, MD.
|
2.0 |
Resistant Hypertension: Reducing Cardiovascular Events
William B. White, MD; David A. Calhoun, MD; Fernando G. Cosio, MD.
|
1.5 |
Obesity in the Peritoneal Dialysis Population: Impact on Modality Selection and Outcomes
Allan J. Collins, MD.
|
The Role of Glycemic Control and How Best to Achieve it
Janet B. McGill, MD.
|
2.0 |
Transplantation: Key Issues for the General Nephrologist
Barbara T. Murphy, MD; Claudio Rigatto, MD; Roslyn B. Mannon, MD, FASN.
|
1.5 |
Post-Transplant Infections: Updating the General Nephrologist
Robert H. Rubin, MD; Mark D. Pescovitz, MD; Emilio Ramos, MD; J. Harold Helderman, MD (moderator)
|
2.0 |
Official Symposium: Medical Crossfire:
An Expert Panel Debates Key Clinical Issues in Mineral Metabolism and Mortality in CKD.
Daniel W. Coyne, MD; Kevin J. Martin, MD; Sharon M. Moe, MD; and Peter Salgo, MD (moderator)
|
1.5 |
Official Symposium: Anemia in Renal Disease:
Update and Case Discusion
Jeffrey S. Berns, MD and David B. Van Wyck, MD. |
1.0 |
AV Fistula: Collaborating With Your Surgeon
Vo D. Nguyen, MD |
1.5 |
Official Symposium: Current Concepts in Neurohormones:
Vasopressin and the Kidney
Robert W. Schrier, MD; Richard H. Sterns, MD |
1.5 |
Membranoproliferative Glomerulonephritis: Clinical Spectrum
Richard J. Glassock, MD.
|
Membranoproliferative Glomerulonephritis: Pathology Update
Patrick D. Walker, MD.
|
2.0 |
Official Symposium: The Role of Iron Deficiency in Anemia Management:
Key Controversies.
Jay B. Wish, MD; Richard A. Zager, MD; Kamyar Kalantar-Zadeh, MD, PhD, MPH;
Rajiv Agarwal, MBBS, MD, FAHA, FASN. (Moderator: Anthony Besarab, MD)
|
 |
To disseminate new knowledge regarding basic, translational, and clinical research discoveries in the field of nephrology.
|
|
To provide exciting scientific and clinical advances in related disciplines in order to expand the scope of research and clinical care in nephrology.
|
|
To discuss contemporary standards and new approaches to clinical care in order to ensure the highest quality of care for patients with renal diseases and related disorders.
|
|
To review, update and put into perspective the recent advances in many key areas of general nephrology, dialysis, transplantation, and hypertension.
|
|
|
See Individual Lecture Pages
|
|  |
|
Each talk, depending
on its length, is accredited
for up to 1.0 AMA PRA Category
1 Credits&trade by the American
Society of Nephrology.
Sometimes talks are organized
into groups of two or more
and paired with a single CME
post-test, which must be completed
along with an evaluation form.
|
| | Date of Web Release: See
individual talks
Credit Eligible Through: See individual talks
Credits/Completion Time: See individual
talks
Target Audiences: Nephrology
Board and Recertification candidates practicing nephrologists
and internists.
Method of participation: Listen to the
talk, read the
PubMed abstracts linked to data slides and talk references, take
the post-test,
read the abstracts linked to post-test answer feedback material.
|
Chronic kidney disease affects 30-40 million Americans, of whom several
thousand require renal replacement therapy. These selected lectures
are chosen by the HDCN editor and ASN Postgraduate Medical Director
to reflect those areas of practice of greatest interest to the
clinician, and areas where recent progress has occurred. The
web extension of these ASN lectures will allow nephrologists
and other physicians who were unable to attend the live sessions
to gain similar benefit from these presentations.
| ACCREDITATION AND DESIGNATION STATEMENTS: |
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
The ASN designates this educational activity AMA PRA Category 1 Credit™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that non-US licensed physicians who participate in this
CME activity are eligible for AMA PRA Category 1 Credit™.
All lectures selected were from Renal Week 2005, and all were put
together under supervision of the ASN Scientific
Program Committee. Web posting of lectures in the free zone was supported
by grants to the ASN from pharmaceutical companies. See each symposium
page for details of industry sponsorship and support.
| FACULTY DISCLOSURE STATEMENTS : |
American Society of Nephrology as well as HDCN have conflict of interest
policies that requires course faculty to disclose any real or
apparent commercial financial affiliations related to the content
of their presentations/materials. It is not assumed that these
financial interests or affiliations will have an adverse impact
on faculty presentations; they are simply noted here to fully
inform participants. Speaker disclosures are posted on each individual talk page.
| DISCLOSURE OF UNLABELED USE: |
This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society
of Nephrology and HDCN do not
recommend the
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
indications,
contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not
meant to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed
or suggested in this activity should not be used by clinicians
without evaluation of their patient's conditions and possible
contraindications on dangers in use, review of any applicable
manufacturer's product information, and comparison with recommendations
of other authorities.
To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Flash 8.0 is required to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the CME
certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send
an email to 
or email@asn-online.org,
or call HDCN at 630-325-3276, Monday through Friday from 10 AM - 4 PM Central Standard Time.
For any general questions concerning ASN CME, please contact the American Society of Nephrology.
| |
